Hemab Therapeutics Inc. Common Stock

COAG | NASDAQ

$41.38

+$0.96 (+2.38%)

At close: Oct 30, 2026, 3:59 PM ET

$41.66

+$0.28 (+0.68%)

After-hours: Oct 30, 2026, 7:48 PM ET

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026
PE Ratio	-28.04	-66.67
PEG Ratio	-0.49	n/a
PS Ratio	n/a	n/a
PB Ratio	2.43	-7.57
P/FCF Ratio	-25.01	-69.26
P/OCF Ratio	-25.01	-69.61
OCF/S Ratio	n/a	n/a
Debt / Equity Ratio	0	-0.01
Quick Ratio	35.85	12.85
Current Ratio	35.85	12.85
Asset Turnover	n/a	n/a
Interest Coverage	n/a	n/a
Return on Equity	-5.32%	11.42%
Return on Assets	-5.16%	-12.94%
Return on Invested Capital	-5.73%	-14.52%
Dividend Yield	n/a	n/a
Payout Ratio	n/a	n/a
FCF Payout Ratio	n/a	n/a
Gross Profit Margin	n/a	n/a
Net Profit Margin	n/a	n/a
Pretax Profit Margin	n/a	n/a
Operating Profit Margin	n/a	n/a
FCF Margin	n/a	n/a
EBITDA Margin	n/a	n/a